Literature DB >> 31889934

Letter to the Editor: Lack of Attention to Epidemiological Study of Neuromyelitis Optica Spectrum Disorder Compared with that of Multiple Sclerosis in Iran.

Abdorreza Naser Moghadasi.   

Abstract

Entities:  

Keywords:  Iran; Multiple sclerosis (MS); Neuromyelitis optica spectrum disorder (NMOSD)

Year:  2019        PMID： 31889934      PMCID： PMC6928582          DOI： 10.7224/1537-2073.2019-043

Source DB:  PubMed          Journal:  Int J MS Care        ISSN： 1537-2073


× No keyword cloud information.
  8 in total

1.  An epidemiological study of neuromyelitis optica in Isfahan.

Authors:  Masoud Etemadifar; Masoumeh Dashti; Reza Vosoughi; Seyed Hossein Abtahi; Sreeram V Ramagopalan; Zahra Nasr
Journal:  Mult Scler       Date:  2014-06-02       Impact factor: 6.312

2.  Neuromyelitis optica spectrum disorders in Iran.

Authors:  Sharareh Eskandarieh; Saharnaz Nedjat; Amir Reza Azimi; Abdorreza Naser Moghadasi; Mohammad Ali Sahraian
Journal:  Mult Scler Relat Disord       Date:  2017-10-09       Impact factor: 4.339

Review 3.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

4.  Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients.

Authors:  M A Sahraian; Z Moinfar; S Khorramnia; M Mohammad Ebrahim
Journal:  Eur J Neurol       Date:  2010-01-20       Impact factor: 6.089

5.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

6.  Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study.

Authors:  Fereshte Ashtari; Ali Safaei; Vahid Shaygannejad; Mohammad Amin Najafi; Sahar Vesal
Journal:  J Res Med Sci       Date:  2017-03-15       Impact factor: 1.852

7.  Correction: Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.

Authors:  Milad Azami; Mohammad Hossein YektaKooshali; Masoumeh Shohani; Ali Khorshidi; Leily Mahmudi
Journal:  PLoS One       Date:  2019-07-09       Impact factor: 3.240

8.  A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.

Authors:  Davood Kashipazha; Seyed Ehsan Mohammadianinejad; Nastaran Majdinasab; Mostafa Azizi; Majid Jafari
Journal:  Iran J Neurol       Date:  2015-10-07
  8 in total
  1 in total

1.  Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder.

Authors:  Seyed Mohammad Forouzannia; Pourya Yarahmadi; Mohammad Alirezaei; Nasim Rezaeimanesh; Abdorreza Naser Moghadasi
Journal:  Caspian J Intern Med       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.